Hiran Orgochem Ltd


BSE: 506170 | NSE: NA | ISIN: INE546E01016 
Market Cap: [Rs.Cr.] 8 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Bulk Drugs

 Discuss this stock

Board Meet

31-May-13 
Hiran Orgochem Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 31, 2013, inter alia, to consider the following : 1. Re-appointment of Mr. Kantilal Hiran as the Managing Director for a period of three years subject to the approval of shareholders at the ensuing Annual General Meeting. 2. To invest in overseas joint venture pursuant to provisions of Section 372A of the Companies Act, 1956. 
15-May-13 
Quarterly Results 
13-Feb-13 
Quarterly Results 
12-Nov-12 
Quarterly Results 
15-Sep-12 
Hiran Orgochem Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 15, 2012 had passed the resolution for shifting of registered office of Hiran Orgochem Limited from Palm Court, M block 601/IA, Link Road, Malad (West), Mumbai - 400064 to Unit No. 439, 4th Floor, IJMIMA - Imitation Jewellery Market Co-op. Society Limited, Off. Link Road, Malad (West), Mumbai-400064 with effect from September 17, 2012. 

AGM

28-Dec-12
AGM : 28.12.2012 Hiran Orgochem Ltd has informed BSE that the 28th Annual General Meeting (AGM) of the Company was held on December 28, 2012. (As Per BSE Announcement Dated On 28.12.2012) Hiran Orgochem Ltd has submitted to BSE a copy of minutes of the 28th Annual General Meeting of the members of the Company held on December 28, 2012. (As per BSE Announcement Dated on 24.01.2013) 
29-Sep-11
AGM 29/09/2011 Hiran Orgochem Ltd has informed BSE that the members at the 27th Annual General Meeting (AGM) of the Company held on September 29, 2011 inter alia, have approved the following resolutions: 1. Adoption of Audited Accounts for the year ended June 30, 2011 alongwith the Reports of the Directors and Auditors thereon. The Balance Sheet as at June 30, 2011, Profit and Loss Account for the year ended as on that date and the reports of Directors and Auditors thereon were received, considered and adopted. 2. Re-Appointment of Mr. Ashok Lunia as a Director of the Company. Mr. Ashok Lunia, who retired by rotation at the said Annual General Meeting was re-appointed as Director of the Company. 3. Re-Appointment of Mr. M. Kailash Kumar as a Director of the Company. Mr. M. Kailash Kumar, who retired by rotation at the said Annual General Meeting was re-appointed as Director of the Company. 4. Appointment of Auditors M/s, Pachori & Associates, Chartered Accountants, were appointed as the Statutory Auditors of the Company for the year 2011-2012. 5. Consideration of the erosion of net worth of the Company as at June 30, 2011 by more than 50% of its peak net worth during the immediately preceding four financial years to comply with the provision of section 23(1)(a)(ii) of the Sick Industrial Companies Act, 1985. (As Per BSE Announcement Website dated on 29.09.2011) 
31-Jul-10
AGM 31/07/2010 Hiran Orgochem Ltd has informed BSE that the members at the 26th Annual General Meeting (AGM) of the Company held on July 31, 2010, inter alia, have accorded to the following: 1. Adoption of the Balance Sheet as at March 31, 2010, Profit and Loss Account for the year ended as on date and the reports of Directors and Auditors thereon. 2. Re-Appointment of Mr. H. N. Bafna & Mr. Mukesh Malik as Directors of the Company. 3. Appointment of M/s. B. L. Dasharda & Associates, Chartered Accountant, as Statutory Auditors of the Company for the year 2010-2011. 4. Appointment of Mr. Naresh K. Hiran as a Director of the Company. 5. Appointment of Mr. Naresh K Hiran as Whole Time Director designated as Director-International Business of the Company from November 01, 2009 to October 31, 2012. 6. Re-Appointment of Mr. Kantilal M. Hiran as Chairman and Managing Director of the Company from June 01, 2010 to May 31, 2013. (As Per BSE Announcement Dated on 02.08.2010) 
29-Aug-09
Hiran Orgochem Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 27, 2009, inter alia, with a view to reward the shareholders on the occasion of the 25th Year, the Company, have recommended a bonus issue of Equity Shares in the ratio of four Equity Shares of the Company of Rs 10/- each fully paid-up for each Equity Share of the Company held by the shareholders of the Company as on the Record Date to be fixed later for this purpose subject to the approval of the shareholders at the forthcoming Annual General Meeting of the Company to be held on August 29, 2009. Hiran Orgochem Ltd has informed BSE that the members at the 25th Annual General Meeting (AGM) of the Company held on August 29, 2009, inter alia, have accorded the following: 1. Adoption of Audited Accounts for the year ended March 31, 2009 alongwith the Reports of the Directors and Auditors thereon. 2. Declaration of Dividend @ 2% (Rs. 0.20 per equity share). 3. Re-appointment of Mr. Vijay Hiran & Mr. Kailash Kumar, as Directors of the Company. 4. Appointment of M/s. B L Dasharda & Associates, Chartered Accountants as Statutory Auditors of the Company. 5. Increase in Authorised Share Capital of the Company from Rs. 15 Crores to Rs. 55 Crores by creation of 4 Crore new Equity Shares of Rs. 10/- each and consequential alternation in the Articles of Association of the Company. 6. Issue of further equity Shares as Bonus Shares in the ratio of 4 new Equity Shares of Rs. 10/- each fully paid up for every 1 new Equity Share of Rs. 10/- each held in the Company on Record Date / Book Closure date as may be determined. (As Per BSE Announcement Website dated on 31.08.2009) 
27-Sep-08
AGM 27/09/2008 Hiran Orgochem Ltd has informed BSE that the members at the 24th Annual General Meeting (AGM) of the Company held on September 27, 2008, inter alia, have accorded the following: 1. Approval of the Audited Statement of Accounts for the year ended March 31, 2008 and Balance Sheet as on that date alongwith the Reports of Directors and Auditors thereon. 2. Declaration of Dividend @ 5%. 3. Re-appointment of Mr. Ashok A Lunia & Mr. Mukesh D Naik, as Directors of the Company. 4. Appointment of M/s. B L Dasharda & Associates, Chartered Accountants as Statutory Auditors of the Company to hold office from the conclusion of the Annual General Meeting until the conclusion of next Annual General Meeting. (As Per BSE Announcement Dated on 29/09/2008) 

EGM

26-May-11
Hiran Orgochem Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company will be held on May 26, 2011 at the registered office of the Company at Palm Court, 601, A/1, M Block, Link Road, Malad (West), Mumbai - 400064 at 2.00 P.M. to appointed M/s. Pachori & Associates, Chartered Accountants as the Statutory Auditors of the Company, to fill the casual vacancy caused by the resignation of M/s. B. L. Dasharda & Associates, Chartered Accountants, Statutory Auditors of the Company, to hold the office until the conclusion of the next Annual General Meeting, on such remuneration as may be fixed by the Board of Directors plus reimbursement of out of pocket expenses. Hiran Orgochem Ltd has informed BSE that the Members at the Extra Ordinary General Meeting (EGM) of the Company held on May 26, 2011, have approved the appointment of M/s. Pachori & Associates, Chartered Accountants as the new Statutory Auditors of the Company to fill the casual vacancy caused by resignation of M/s. B. L. Dasharda & Associates, Chartered Accountants. (As Per BSE Annoncement Website Dated on 28/05/2011) 
30-Jan-07
Hiran Orgochem Ltd has informed BSE that an Extra-Ordinary General Meeting (EGM) of the members of the Company will be held on January 30, 2007, inter alia, to transact the following: 1. Commencement of and undertaking any or all the activities specified in the sub-clause Nos. 69 and 70 of Clause III (C) of the Memorandum of Association of the Company and to take all such actions and do all such things as may be necessary from time to time in connection with the same, subject to necessary provisions and approvals. 2. Increase in the Authorised Share Capital of the Company from Rs 11,00,00,000/- divided into 1,10,00,000 Equity Shares of Rs 10/- each to Rs 15,00,00,000/- divided into 1,50,00,000 Equity Shares of Rs 10/- each by creation of an additional 40,00,000 Equity Shares of Rs 10/- each and consequential amendments in the Memorandum & Articles of Association of the Company. 3. To offer, issue and allot on a preferential basis upto : i. 10,00,000 Equity Shares of Rs 10/- each for cash at a premium of Rs 120/- per share (the pricing which is determined in accordance with the SEBI Guidelines as applicable) aggregating Rs 13,00,00,000/-, by way of Preferential allotment(s) to persons / entities including the promoters of the Company, whether such allottees are shareholders of the Company or not; and ii. 20,00,000 Optionally Fully Convertible Warrants (OFCWs) ("Warrants") to persons / entities including the promoters of the Company, whether such allottees are shareholders of the Company or not, each warrant convertible at the sole option of the holder thereof, any time on or after April 01, 2007 but before expiry of 18 months from the date of allotment thereof, into 1 fully paid up equity share of the Company of face value of Rs 10/- at an exercise price (including premium) of Rs 130/- per warrant (the pricing which is determined in accordance with the SEBI Guidelines as applicable) aggregating Rs 26,00,00,000/-, and the issue of fresh equity shares on the conversion of the Warrants, on such further term conditions of the Warrants as may be finalized by the Board of Directors and also to seek listing of such securities On the stock exchange(s) in consultation with Advisor(s) appointed. for the said purpose, as may be deemed appropriate, fit and proper by the Board, subject to necessary provisions & approvals. Hiran Orgochem Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on January 30, 2007, inter alia, have unanimously passed the following resolutions: 1. Consent to the Board of Directors for commencement of and undertaking any or all the activities specified in the sub-clause Nos. 69 and 70 of Clause III (C) of the Memorandum of Association of the Company. 2. Increase in Authorised Share Capital from Rs 11,00,00,000/- to Rs 15,00,00,000/- divided into 1,50,00,000 Equity Shares of Rs 10/- each by creation of an additional 40,00,000 Equity Shares of Rs 10/- each and Alteration of Memorandum of Association of the Company consequent upon the increase in the Authorised Share Capital. 3. Alteration of the Articles of Association consequent upon increase in the Authorised Share Capital. 4. Consent to the Board of Directors to offer, issue and allot 10,00,000 Equity Shares of Rs 10/- each for cash at a premium of Rs 120/- per share and 20,00,000 Optionally Fully Convertible Warrants (OFCWs) (Warrants), each Warrant convertible at the sole option of the holder thereof, anytime on or after April 01, 2007 but before expiry of 18 months from the date of allotment thereof, into 1 fully paid up equity share of the Company of face value of Rs 10/- at an exercise price (including premium) of Rs 130/- per warrant on Preferential Allotment basis to certain persons / entities including the promoters of the Company, whether such allottes are shareholders of the Company or not. (As Per BSE Announcement Website Dated on 30/01/2007) Hiran Orgochem Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 13, 2007, interalia, to consider the issue and allotment of 10,00,000 Equity Shares and 20,00,000 Optionally Fully Convertible Warrants (OFCWs) (Warrants) on preferential basis to promoters and others in accordance with the Special Resolution passed by the members of the Company u/s 81(1A) of the Companies Act, 1956 at the Extra-Ordinary General Meeting held on January 30, 2007. (As Per BSE Announcement Website Dated on 09/02/2007) Extra Ordinary General Meeting held on January 30, 2007. 1. 9,10,000 Equity Shares of Rs 10/- each for cash at a premium of Rs 120/- per share. 2. 16,75,000 Optionally Fully Convertible Warrants (OFCWs) (Warrants), each Warrant convertible at the sole option of the holders thereof, any time on or after April 01, 2007 but before expiry of 18 months from the date of allotment thereof, into 1 fully paid up equity share of the Company of face value of Rs 10/- at an exercise price (including premium) of Rs 130/- per warrant. (As Per BSE Announcement Website Dated on 13/02/2007) 
09-Sep-05
EGM 09/09/2005 To consider: 1. Increase in Authorised Share Capital of the Company from Rs 7,00,00,000/- divided into 70,00,000 Equity Shares of Rs 10/- each to Rs 11,00,00,000/- divided into 1,10,00,000 Equity Shares of Rs 10/- each by creation of an additional 40,00,000 Equity Shares of Rs 10/- each and consequential amendment in Memorandum & Articles of Association of the Company. 2. Authority to the Board for offering, issuing and allotting on a preferential basis upto: a. 15,00,000 Equity Shares of Rs 10/- each for cash at a premium of Rs 120/- per share (the pricing which is determined in accordance with the SEBI Guidelines as applicable) aggregating Rs 19,50,00,000/- in one or more tranches, at such time or times, in such manner, form and numbers as may be prescribed while granting permission(s), sanction(s) and approval(s) by the aforesaid authorities and/or which the Board may at its absolute discretion consider proper, desirable and expedient by way of Preferential allotment(s) to persons / entities including the promoters of the Company, whether such allottees are shareholders of the Company or not; and b. 23,00,000 Optionally Fully Convertible Warrants (OFCWs) ("Warrants") to persons / entities including the promoters of the Company, whether such allottees are shareholders of the Company or not, each Warrant convertible at the sole option of the holder thereof, any time on or after April 01, 2006 but before expiry of 18 months from the date of allotment thereof, into 1 fully paid up equity share of the Company of face value of Rs 10/- at an exercise price (including premium) of Rs 130/- per warrant (the pricing which is determined in accordance with the SEBI Guidelines as applicable) aggregating Rs 29,90,00,000/-, and the issue of fresh equity shares on the conversion of the Warrants, on such further terms and conditions of the Warrants as may be finalized by the Board of Directors. The company has informed that the members at the Extra Ordinary General Meeting (EGM) of the Company held on September 09, 2005, inter alia, have unanimously passed the following the resolutions : 1. Increase in Authorised Share Capital from Rs 7,00,00,000/- to Rs 11,00,00,000/- divided into 1,10,00,000 Equity Shares of Rs 10/- each by creation of an additional 40,00,000 Equity Shares of Rs 10/- each and Alteration of Memorandum and Articles of Association of the Company consequent upon the increase in the Authorised Share Capital. 2. Consent to the Board of Directors to offer, issue and allot 15,00,000 Equity Shares of Rs 10/- each for cash at par at a premium of Rs 120/- per share and 23,00,000 Optionally Fully Convertible Warrants (OFCWs) (Warrants), each Warrant convertible at the sole option of the holder thereof, anytime on or after April 01, 2006 but before expiry of 18 monthsfrom the date of allotment thereof, into 1 fully paid up equity share of the Company of face value of Rs 10/- at an exercise price (including premium) of Rs 130/- per warrant on Preferential Allotment basis to certain persons / entities including the promoters of the Company, whether such allottes are shareholders of the Company or not. (As per BSE Bulletin dated on 12/09/2005) 
14-Mar-05
EGM 14/03/2005 To cosider: 1.To issue of further Equity Share Capital not exceeding 10,00,000 Equity Shares of Rs 10/- each for cash at premium of Rs 40/- per share to persons/entities other than the promoters of the Company on preferential allotment basis. 2. Authority to the Board to increase the borrowing power in terms of Section 293(1)(d) and any other applicable provisions of the Companies Act, 1956, such that the amounts so borrowed and outstanding at any time shall notexceed the limit of Rs 75,00,00,000/-. The company has informed that the members at the Extra Ordinary General Meeting of the Company held on March 14, 2005, inter alia, have approved the following: 1. Authority to the Board of Directors to offer, issue and allot 10,00,000 Equity Shares of Rs 10/- each for cash at par at premium of Rs 40/- per share on Preferential Allotment basis to certain persons / entities other than the promoters of the Company. 2. Authority to Board of Directors of the Company under Section 293(1)(d) of the Companies Act, 1956 to borrow in excess of the aggregate of the paid up capital of the Company and its free Reserves - upto a limit of Rs 750 million at any time. (As per BSE bulletin dated on 14/03/2005) The Board has allotted 9,85,000 Equity Shares of Rs 10/- each for cash at a premium of Rs 40/- per share on preferential issue basis in accordance with the resolution passed by the members at the Extra Ordinary General Meeting held on March 14, 2005. (As per BSE Bulletin dated on 28/03/2005) 
11-May-04
EGM 11/05/2004 To consider offer, issue & allotment 10,00,000 equity shares of Rs. 10/- each for at a premium of Rs. 15/- per share in one or more tranches at such time or times, in such manner, form and numbers as may be prescribed while granting approvals by the aforesaid authorities and/or which the board may at its absolute discretion consider proper, desirable and expedient by way of Preferential allotment to persons/entities other than promoters of the company. The company has informed that at the EGM held on 11/05/2004, the members of the company have approved the allotment of 10,00,000 equity shares of of Rs.10/- each for cash at a premium ofRs.15/- per share on preferential allotment basis. (As per BSE bulletin dated on 11/05/2004) 

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Lupin 34,460.10 27.34 7.11 21.23 23.4 22.7 0.30
Divi's Lab. 13,113.05 21.45 5.14 13.41 27.3 34.1 0.02
Jubilant Life 2,324.98 29.54 1.25 21.18 3.1 6.4 1.43
Shilpa Medicare 699.60 13.97 2.39 9.34 16.3 18.0 0.19
Hikal 668.29 26.19 1.95 5.65 22.4 18.2 1.53
Elder Pharma 584.57 6.35 0.76 6.59 12.9 13.0 1.25
Dishman Pharma. 547.55 11.31 0.81 5.44 6.8 10.2 0.80
Vinati Organics 538.41 7.84 2.23 5.63 33.2 31.3 0.75
Orchid Chemicals 414.25 0.00 0.45 7.67 9.7 8.3 1.75
Shasun Pharma. 411.48 14.93 1.52 7.48 14.0 8.9 1.05
Nectar Lifesci. 356.19 4.16 0.41 6.25 9.7 11.2 1.22
Sequent Scien. 335.72 0.00 2.20 7.62 -3.9 5.9 1.58
Suven Life Scie. 284.41 9.22 1.84 10.21 11.3 9.1 0.64
Aarti Drugs 260.37 5.72 1.25 4.78 13.5 13.7 1.48
Granules India 260.08 8.62 0.96 4.12 11.7 15.2 0.57

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Kantilal M Hiran , Chairman & Managing Director 

H N Bafna , Director 

M Kailash Kumar , Director 

Ashok Lunia , Director 


Company Head Office / Quarters:
Unit No 439 4th Floor IJMIMA,
Link Road Malad(West),
Mumbai,
Maharashtra-400064
Phone : 91-022-40953000
Fax : 91-022-40953099
E-mail :
info@hiranorgochem.com
hiran@vsnl.com
Web : http://www.hiranorgochem.com
Registrars:
Bigshare Services Pvt Ltd
E-2/3 Ansa Indl Est
Saki Vihar Road
Sakinaka Andheri(E)
Mumbai - 400072

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Open : India Finsec
Economic Events
list No economic event today
Results
list No result today